These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 12522023)
21. Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia. Al-Mazrou Y; Tumsah S; Khalil M; Al-Jeffri M; Afzal MA; al-Ghamdy Y; Mishkhas A; Essa M J Trop Pediatr; 2002 Dec; 48(6):354-8. PubMed ID: 12521278 [TBL] [Abstract][Full Text] [Related]
22. Surveillance of measles-mumps-rubella vaccine-associated aseptic meningitis in Germany. Schlipköter U; Mühlberger N; von Kries R; Weil J Infection; 2002 Dec; 30(6):351-5. PubMed ID: 12478324 [TBL] [Abstract][Full Text] [Related]
23. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial. Sood A; Mitra M; Joshi HA; Nayak US; Siddaiah P; Babu TR; Mahapatro S; Sanmukhani J; Gupta G; Mittal R; Glueck R Hum Vaccin Immunother; 2017 Jul; 13(7):1523-1530. PubMed ID: 28362563 [TBL] [Abstract][Full Text] [Related]
24. Aseptic meningitis after vaccination against measles and mumps. Cizman M; Mozetic M; Radescek-Rakar R; Pleterski-Rigler D; Susec-Michieli M Pediatr Infect Dis J; 1989 May; 8(5):302-8. PubMed ID: 2726323 [TBL] [Abstract][Full Text] [Related]
25. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Marin M; Broder KR; Temte JL; Snider DE; Seward JF; MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530 [TBL] [Abstract][Full Text] [Related]
26. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387 [TBL] [Abstract][Full Text] [Related]
28. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Wellington K; Goa KL Drugs; 2003; 63(19):2107-26. PubMed ID: 12962524 [TBL] [Abstract][Full Text] [Related]
29. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age. Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM; Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine. LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532 [TBL] [Abstract][Full Text] [Related]
31. [Adverse effects following vaccinations and effectiveness of different live vaccines against mumps]. Magdzik W; Zieliński A Przegl Epidemiol; 2002; 56(3):377-89. PubMed ID: 12608087 [TBL] [Abstract][Full Text] [Related]
32. Is aseptic meningitis following mumps vaccination underreported in Japan? Uozumi Y; Miyahara M; Osaki K; Negoro M; Suga S Pediatr Int; 2022 Jan; 64(1):e14968. PubMed ID: 35189008 [No Abstract] [Full Text] [Related]
33. [Estimation of the efficacy of three strains of mumps vaccines during an epidemic of mumps in the Geneva canton (Switzerland)]. Chamot E; Toscani L; Egger P; Germann D; Bourquin C Rev Epidemiol Sante Publique; 1998 Mar; 46(2):100-7. PubMed ID: 9592852 [TBL] [Abstract][Full Text] [Related]
34. Comment to "Aseptic meningitis after vaccination with L-Zagreb mumps strain-virologically confirmed cases" faulty calculation of rates. Tesović G; Lesnikar V; Begovac J Vaccine; 2007 Jul; 25(28):5124-5. PubMed ID: 17555847 [No Abstract] [Full Text] [Related]
35. Effect of age on the incidence of aseptic meningitis following immunization with monovalent mumps vaccine. Muta H; Nagai T; Ito Y; Ihara T; Nakayama T Vaccine; 2015 Nov; 33(45):6049-53. PubMed ID: 26431987 [TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials. Leung JH; Hirai HW; Tsoi KK Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133 [TBL] [Abstract][Full Text] [Related]
37. [Clinical and laboratory features of aseptic meningitis associated with measles-mumps-rubella vaccine]. Lucena R; Gomes I; Nunes L; Cunha S; Dourado I; Teixeira Mda G; Goes J; Cardoso E; Rodrigues B; Cardoso A; Barreto ML; Melo A Rev Panam Salud Publica; 2002 Oct; 12(4):258-61. PubMed ID: 12431357 [TBL] [Abstract][Full Text] [Related]
38. Aseptic meningitis in a large MMR vaccine campaign (590,609 people) in Curitiba, Paraná, Brazil, 1998. Arruda WO; Kondageski C Rev Inst Med Trop Sao Paulo; 2001; 43(5):301-2. PubMed ID: 11696855 [TBL] [Abstract][Full Text] [Related]
39. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. Barlow WE; Davis RL; Glasser JW; Rhodes PH; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Ward JI; Marcy SM; DeStefano F; Chen RT; Immanuel V; Pearson JA; Vadheim CM; Rebolledo V; Christakis D; Benson PJ; Lewis N; N Engl J Med; 2001 Aug; 345(9):656-61. PubMed ID: 11547719 [TBL] [Abstract][Full Text] [Related]
40. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children? Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]